8.7565
price up icon0.01%   0.0265
 
loading
Schlusskurs vom Vortag:
$8.73
Offen:
$8.665
24-Stunden-Volumen:
1.26M
Relative Volume:
0.49
Marktkapitalisierung:
$1.07B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-4.3349
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
-10.46%
1M Leistung:
-18.33%
6M Leistung:
-59.03%
1J Leistung:
-76.44%
1-Tages-Spanne:
Value
$8.54
$9.03
1-Wochen-Bereich:
Value
$8.54
$9.83
52-Wochen-Spanne:
Value
$8.54
$37.73

10 X Genomics Inc Stock (TXG) Company Profile

Name
Firmenname
10 X Genomics Inc
Name
Telefon
(925) 401-7300
Name
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Mitarbeiter
0
Name
Twitter
@10xgenomics
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
TXG's Discussions on Twitter

Vergleichen Sie TXG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
TXG
10 X Genomics Inc
8.76 1.07B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
226.91 37.69B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
56.68 10.89B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
46.49 8.31B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
86.55 7.66B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
36.98 6.43B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-13 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-03 Eingeleitet Leerink Partners Outperform
2024-07-22 Hochstufung Jefferies Hold → Buy
2024-07-18 Herabstufung JP Morgan Overweight → Neutral
2024-07-10 Herabstufung Deutsche Bank Buy → Hold
2024-06-27 Herabstufung Wolfe Research Outperform → Peer Perform
2024-06-25 Herabstufung Guggenheim Buy → Neutral
2024-06-03 Fortgesetzt Jefferies Hold
2024-05-01 Herabstufung TD Cowen Buy → Hold
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Hochstufung BofA Securities Underperform → Neutral
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-10 Eingeleitet Barclays Overweight
2023-03-31 Eingeleitet Stephens Overweight
2023-02-02 Eingeleitet UBS Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-08-18 Herabstufung Goldman Neutral → Sell
2022-07-25 Eingeleitet Canaccord Genuity Buy
2022-07-15 Herabstufung BofA Securities Neutral → Underperform
2022-07-15 Herabstufung William Blair Outperform → Mkt Perform
2021-10-15 Fortgesetzt Cowen Outperform
2021-09-14 Herabstufung BofA Securities Buy → Neutral
2021-03-15 Eingeleitet William Blair Outperform
2020-12-02 Eingeleitet Goldman Neutral
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-07-10 Eingeleitet Stifel Buy
2020-03-05 Eingeleitet Guggenheim Buy
2020-01-07 Eingeleitet Citigroup Buy
2019-10-07 Eingeleitet BofA/Merrill Buy
2019-10-07 Eingeleitet Cowen Outperform
2019-10-07 Eingeleitet JP Morgan Overweight
2019-09-24 Eingeleitet Evercore ISI Outperform
Alle ansehen

10 X Genomics Inc Aktie (TXG) Neueste Nachrichten

pulisher
03:46 AM

IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 32,555 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

03:46 AM
pulisher
Mar 28, 2025

10X Genomics stock plunges to 52-week low of $9.27 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

10X Genomics stock plunges to 52-week low of $9.27 - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

We Think 10x Genomics (NASDAQ:TXG) Can Easily Afford To Drive Business Growth - Yahoo Finance

Mar 27, 2025
pulisher
Mar 21, 2025

10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus.com

Mar 21, 2025
pulisher
Mar 20, 2025

10x Genomics: Lower Cost Innovation May Drive A Rebound - Seeking Alpha

Mar 20, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025
pulisher
Mar 11, 2025

Long Read Sequencing Market Top Companies Study10X Genomics, - openPR

Mar 11, 2025
pulisher
Mar 10, 2025

Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex

Mar 10, 2025
pulisher
Mar 09, 2025

10x Genomics IncOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

10x Genomics’ (TXG) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Citigroup Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Strategic Move: Healthcare Giant Zimmer Biomet Taps Communications Veteran from 10x Genomics - Stock Titan

Mar 06, 2025
pulisher
Mar 05, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

10x Genomics Dodges Appeal In DNA Analysis Patent Clash - Law 360 UK

Mar 05, 2025
pulisher
Mar 05, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Sells 1,641 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Sanctuary Advisors LLC Purchases 6,474 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in 10x Genomics, Inc. (NASDAQ:TXG) Expands By 34.4% - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Plann - GuruFocus.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences’ Planned ATAC Products - The Malaysian Reserve

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics secures injunction against Parse Biosciences - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products (TXG:NASDAQ) - Seeking Alpha

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products – Company Announcement - Financial Times

Mar 03, 2025
pulisher
Mar 02, 2025

10 Promising Biotech Stocks to Invest in (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

ARK Investment Management LLC Purchases 1,193,712 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

SVB Wealth LLC Acquires Shares of 522,609 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Purchases 50,722 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ING Groep NV Acquires New Shares in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

10x Genomics, Inc. (NASDAQ:TXG) CEO Sells $56,368.44 in Stock - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Director of 10x Genomics Picks Up 184% More Stock - Simply Wall St

Feb 27, 2025
pulisher
Feb 27, 2025

Oxford Nanopore Expands Compatibility With 10x Genomics To Unlock Deeper Insights in Single-Cell Transcriptomics - Technology Networks

Feb 27, 2025
pulisher
Feb 26, 2025

Insider Buying: 10x Genomics, Inc. (NASDAQ:TXG) Director Buys 40,000 Shares of Stock - MarketBeat

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics’ president sells $50,602 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics CEO Serge Saxonov sells $56,346 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics CEO Serge Saxonov sells $56,346 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics' president sells $50,602 in stock - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

10x genomics director Alan Mateo acquires $445,572 in stock - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

10x Genomics Director Mateo Alan Acquires 40,000 Shares - TradingView

Feb 25, 2025
pulisher
Feb 24, 2025

Alberta Investment Management Corp Takes $3.21 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, - GuruFocus.com

Feb 23, 2025
pulisher
Feb 23, 2025

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis – Company AnnouncementFT.com - Financial Times

Feb 23, 2025
pulisher
Feb 23, 2025

Can 10x Genomics' New 8-Million Cell Platform Transform Genomic Research? - Stock Titan

Feb 23, 2025
pulisher
Feb 22, 2025

Harvard, 10x Genomics Settle Patent Dispute With Vizgen - The Harvard Crimson

Feb 22, 2025
pulisher
Feb 21, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Feb 21, 2025
pulisher
Feb 20, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference - The Eastern Progress Online

Feb 19, 2025
pulisher
Feb 19, 2025

10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Q1 EPS Estimates for 10x Genomics Lowered by Leerink Partnrs - MarketBeat

Feb 19, 2025

Finanzdaten der 10 X Genomics Inc-Aktie (TXG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

10 X Genomics Inc-Aktie (TXG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Saxonov Serge
Chief Executive Officer
Feb 28 '25
Sale
10.63
7,942
84,393
871,540
health_information_services PHR
$25.31
price down icon 0.74%
$4.4399
price up icon 0.44%
$19.37
price up icon 0.54%
$23.02
price up icon 2.58%
$17.84
price down icon 1.44%
health_information_services WAY
$37.04
price down icon 0.94%
Kapitalisierung:     |  Volumen (24h):